Dupilumab
Eczema Treatments
Dupilumab
Eczema Treatments

Dupilumab

Use Dupilumab (Dupixent®) as prescribed to help treat moderate to severe eczema (atopic dermatitis) by targeting key inflammatory pathways involved in chronic skin inflammation, helping reduce itching, redness, and flare frequency.
Dupilumab is an injectable biologic medication that blocks specific immune pathways responsible for eczema inflammation. It reduces redness, itching, and the severity of flare-ups.
Dupilumab is prescribed for individuals with moderate to severe eczema who have not responded to topical treatments or phototherapy.
Significant improvements are often seen within 2–4 weeks, with continued benefits over several months of use.
Dupilumab is prescribed for adults and adolescents with moderate to severe eczema who have not responded adequately to topical treatments or for whom topical therapies are not appropriate. It is given as a subcutaneous injection under clinician supervision. See pricing details here.

Real patients, real results

How effective is Dupilumab

Clinically proven results

Significant and sustained improvement in eczema severity, itch, and quality of life.*
Clinical studies show that Dupilumab reduces eczema symptoms and flare frequency over time, with many patients achieving clear or almost clear skin and lasting itch relief with continued treatment.
*In clinical trials, a substantial percentage of patients treated with dupilumab experienced meaningful improvement in eczema severity and itch reduction within 16 weeks compared to placebo.
Dupilumab should be used only as prescribed. For more details, see Important Safety Information.

How DermOnDemand Works

Common Question

Side effects include injection site reactions, conjunctivitis, and mild respiratory symptoms like a sore throat.
It is given as an injection every two weeks. Your doctor will provide instructions on how to administer it at home if needed.